| The Spanish Society of Nephrology (SENEFRO) commentary to the Spain GBD 2016 report: Keeping chronic kidney disease out of sight of health authorities will only magnify the problem |
14 |
| Anemia of chronic kidney disease: Protocol of study, management and referral to Nephrology |
13 |
| Targeting of regulated necrosis in kidney disease |
8 |
| Role of pyrophosphate in vascular calcification in chronic kidney disease |
7 |
| Dietary Acid Load: mechanisms and evidence of its health repercussions |
7 |
| Chronic kidney disease in Spain: Prevalence and impact of accumulation of cardiovascular risk factorsN |
6 |
| Onco-Nephrology: Cancer, chemotherapy and kidney |
5 |
| Osteoporosis, bone mineral density and CKD-MBD (II): Therapeutic implications |
5 |
| Native vitamin D in pre-dialysis chronic kidney disease |
5 |
| Prospective randomised multicentre study to demonstrate the benefits of haemodialysis without acetate (with citrate): ABC-treat Study. Acute effect of citrate |
4 |
| MAP3K kinases and kidney injury |
4 |
| Calciphylaxis in patients with chronic kidney disease: A disease which is still bewildering and potentially fatal |
4 |
| Mycophenolate mofetil-induced mouth ulcers in a kidney transplant patient: Case report and literature review |
4 |
| Prevalence of malnutrition-inflammation complex syndrome and its correlation with thyroid hormones in chronic haemodialysis patients |
4 |
| Osteoporosis, bone mineral density and CKD-MBD complex (I): Diagnostic considerations |
4 |
| Could Notch signaling pathway be a potential therapeutic option in renal diseases? |
3 |
| The anaemia control model: Does it help nephrologists in therapeutic decision-making in the management of anaemia? |
3 |
| Validation of KDRI/KDPI for the selection of expanded criteria kidney donors |
3 |
| Protein-energy wasting syndrome in advanced chronic kidney disease: prevalence and specific clinical characteristics |
3 |
| The renin-angiotensin-aldosterone system blockade in patients with advanced diabetic kidney disease |
3 |
| Correction of 25-OH-vitamin D deficiency improves control of secondary hyperparathyroidism and reduces the inflammation in stable haemodialysis patients |
3 |
| The role of bioelectrical impedance analysis, NT-ProBNP and inferior vena cava sonography in the assessment of body fluid volume in children with nephrotic syndrome |
3 |
| Gastrointestinal lesions in chronic kidney disease patients with anaemia |
3 |
| Chronic renal disease in Spain: prevalence and related factors in persons with diabetes mellitus older than 64 years |
3 |
| The use of cell cycle arrest biomarkers in the early detection of acute kidney injury. Is this the new renal troponin? |
3 |
| Does renal function improve after parathyroidectomy in primary hyperparathyroidism? |
3 |
| Sacubitril/valsartan in chronic kidney disease, the nephrologist point of view |
3 |
| Evaluation of the influence of the surface membrane and blood flow in medium cut-off (MCO) dialyzers |
3 |
| Hyperuricemia is associated with progression of chronic kidney disease in patients with reduced functioning kidney mass |
2 |
| Association between renal dysfunction and metalloproteinase (MMP)-9 activity in hypertensive patients |
2 |
| Investigation of dose-dependent effects of berberine against renal ischemia/reperfusion injury in experimental diabetic rats |
2 |
| FGF23 in hemodialysis patients is associated with left ventricular hypertrophy and reduced ejection fraction |
2 |
| Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as biological markers of interest in kidney disease |
2 |
| Fabry nephropathy. Role of nephrologist and clinical variables associated with the diagnosis |
2 |
| Epidemiology of hyperkalemia in chronic kidney disease |
2 |
| Kidney transplant from controlled donors following circulatory death: Results from the GEODAS-3 multicentre study |
2 |
| Podocyturia in paediatric patients with Fabry disease |
2 |
| Does the Kidney Donor Profile Index (KDPI) predict graft and patient survival in a Spanish population? |
2 |
| Serum 25-hydroxyvitamin D level is negatively associated with serum phosphorus level among stage 3a-5 chronic kidney disease patients |
2 |
| Risk of hospitalization associated with body mass index and weight changes among prevalent haemodialysis patients |
2 |
| Acquired partial lipodystrophy and C3 glomerulopathy: Dysregulation of the complement system as a common pathogenic mechanism |
2 |
| Prospective evaluation of the development of contrast-induced nephropathy in patients with acute coronary syndrome undergoing rotational coronary angiography vs. conventional coronary angiography: CINERAMA study |
2 |
| Assessment of urinary TWEAK levels in Mexican patients with untreated lupus nephritis: An exploratory study |
2 |
| A new generation of cellulose triacetate suitable for online haemodiafiltration |
2 |
| MDRD or CKD-EPI for glomerular filtration rate estimation in living kidney donors |
1 |
| Overview of autosomal dominant polycystic kidney disease in the south of Spain |
1 |
| Peritoneal dialysis: A factor of risk or protection for posterior reversible encephalopathy syndrome? review of the literature |
1 |
| Socio-sanitary profile and information for living kidney donors and recipients in three Andalusian hospitals |
1 |
| Bone and mineral metabolism at 55 haemodialysis centres in Lima |
1 |
| Thermal disinfection in hemodialysis using the A0 concept as dispenser |
1 |
